Souhaitez-vous accéder aux communiqués récents ?

Year-over-year improvements in gross profit, Adjusted EBITDA1 and net earnings. Closing backlog1 of $13.0 billion and reaffirmed 2026 guidance. WINNIPEG, Manitoba, May 07, 2026 (GLOBE NEWSWIRE) --...

NASHVILLE, Tenn., May 07, 2026 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”), a leading lodging and hospitality real estate investment trust that specializes in...

Total Investment Income of $17.6 Million and Core Investment Income1 of $14.8 Million Announces Third Quarter 2026 Base Distribution of $0.27 Per Share, and Second Quarter Supplemental Cash...

Q1 2026 revenue of $34.3 millionQ1 2026 Adjusted EBITDA* of $1.8 million and GAAP Net Loss of $4.5 millionAnnounced acquisition of Nokia’s Fixed Wireless Access business, expected to close Q4 2026 ...

ST. JOHN'S, Neufundland und Labrador, May 07, 2026 (GLOBE NEWSWIRE) -- Kraken Robotics Inc. („Kraken“ oder das „Unternehmen“) (TSX-V: PNG, OTCQB: KRKNF) gibt bekannt, während der SAHA Messe in...

DALLAS, May 07, 2026 (GLOBE NEWSWIRE) -- RAVE Restaurant Group, Inc. (NASDAQ: RAVE) today reported financial results for the third quarter of fiscal 2026 ended March 29, 2026. Third Quarter...

- Q1 2026 revenue of €197 million for YORVIPATH® and €44 million for SKYTROFA® - More than 1,000 new patient enrollments for YORVIPATH in the U.S. in Q1 - As of May 1, more than 60 YUVIWEL®...

The Company delivered record quarterly net gaming revenue of €64.4 million and Adj. EBITDA of €6.0 million Total revenue was €60.3 mm in Q1 2026, while net gaming revenue1 was €64.4 mm, 13% above Q1...

– Decisions on regulatory approval from EMA, UK, and Switzerland for obicetrapib and obicetrapib/ezetimibe fixed-dose combination expected in 2H26, and based on the outcomes, with potential launches...

Privia Health Reports First Quarter 2026 Financial Results; Strong First Quarter Performance and Operating Execution; Reiterated Full-Year 2026 Guidance